These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33367614)

  • 1. Cynaroside inhibits Leishmania donovani UDP-galactopyranose mutase and induces reactive oxygen species to exert antileishmanial response.
    Tabrez S; Rahman F; Ali R; Alouffi AS; Akand SK; Alshehri BM; Alshammari FA; Alam A; Alaidarous MA; Banawas S; Dukhyil AAB; Rub A
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33367614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.
    Kashif M; Tabrez S; Husein A; Arish M; Kalaiarasan P; Manna PP; Subbarao N; Akhter Y; Rub A
    J Cell Biochem; 2018 Mar; 119(3):2653-2665. PubMed ID: 29058760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of potential inhibitors for autophagy-related protein 8 as antileishmanial agents.
    Rahman F; Ali R; Tabrez S; Mobeen A; Akand SK; Arish M; AlAsmari AF; Ali N; Rub A
    Chem Biol Drug Des; 2022 Jun; 99(6):816-827. PubMed ID: 35147279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
    Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
    Kaur J; Sundar S; Singh N
    J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkyl galactofuranosides strongly interact with Leishmania donovani membrane and provide antileishmanial activity.
    Suleman M; Gangneux JP; Legentil L; Belaz S; Cabezas Y; Manuel C; Dureau R; Sergent O; Burel A; Daligault F; Ferrières V; Robert-Gangneux F
    Antimicrob Agents Chemother; 2014; 58(4):2156-66. PubMed ID: 24468785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.
    Mittra B; Saha A; Chowdhury AR; Pal C; Mandal S; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
    Mol Med; 2000 Jun; 6(6):527-41. PubMed ID: 10972088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
    Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
    J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperidin Targets
    Tabrez S; Rahman F; Ali R; Akand SK; Alaidarous MA; Banawas S; Dukhyil AAB; Rub A
    ACS Omega; 2021 Mar; 6(12):8112-8118. PubMed ID: 33817470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against
    Cabral LIL; Pomel S; Cojean S; Amado PSM; Loiseau PM; Cristiano MLS
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioassay-based Corchorus capsularis L. leaf-derived β-sitosterol exerts antileishmanial effects against Leishmania donovani by targeting trypanothione reductase.
    Pramanik PK; Chakraborti S; Bagchi A; Chakraborti T
    Sci Rep; 2020 Nov; 10(1):20440. PubMed ID: 33235245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents.
    Ansari SB; Kamboj S; Ramalingam K; Meena R; Lal J; Kant R; Shukla SK; Goyal N; Reddy DN
    Bioorg Chem; 2023 Aug; 137():106593. PubMed ID: 37186964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
    Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
    Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of
    Broni E; Kwofie SK; Asiedu SO; Miller WA; Wilson MD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
    Sane SA; Shakya N; Haq W; Gupta S
    J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
    Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
    ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.